EX-23.1 14 jazzq42012ex231.htm CONSENT OF KPMG, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM JAZZ Q4 2012 EX 23.1

Exhibit 23.1

Consent of KPMG, Independent Registered Public Accounting Firm

 

The Board of Directors
Jazz Pharmaceuticals plc
We consent to the incorporation by reference in the registration statement (No. 333‑179075) on Form S-8, and the registration statement (No. 333‑179080) on Form S-3, of Jazz Pharmaceuticals plc of our reports dated February 26, 2013, with respect to the consolidated balance sheet of Jazz Pharmaceuticals plc as of December 31, 2012, and the related consolidated statements of income, comprehensive income, shareholders' equity and cash flows for the year then ended, and the related financial statement schedule for the year ended December 31, 2012, and the effectiveness of internal control over financial reporting as of December 31, 2012, which reports appear in the December 31, 2012 annual report on Form 10‑K of Jazz Pharmaceuticals plc.

 

/s/ KPMG
 
Dublin, Ireland
February 26, 2013